Airway Obstruction: Clinical Trials

10 trials for Airway Obstruction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed, 1 terminated. 10 Phase 1, 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 110Completed 9, Terminated 1
Phase 25Completed 4, Terminated 1

Follow Airway Obstruction: new trials by email Literature Review of Airway Obstruction trials Research Report on Airway Obstruction

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Epigallocatechin-3-gallate (EGCG) for Supportive and Symptomatic Management in Patients With Esophageal Cancer
EGCG - Esophageal Obstruction
Phase 1CompletedShandong Cancer Hospital and Institute182021-08-202024-04-03
A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies for Safety, Efficacy, & Superiority in 1520 Male & Female Volunteers
Mometasone Furoate Monohydrate Nasal Spray, 50 μg/act., Nasonex® Nasal Spray, 50 μg/actuation, Nasonex® Nasal Spray Suspnsn, 50 μg/actuation - Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis
Phase 1CompletedMylan Pharmaceuticals Inc13072013-09-012014-04-09
Effectiveness of Continuous Negative External Pressure in Preventing Upper Airway Impairment During Routine Colonoscopy
Airway Management System (AMS) - Airway Obstruction, Apnea
Phase 1 / Phase 2Completed5i Sciences, Inc.542013-03-012014-08-06
Effects of AkPharma's Calcium Glycerophosphate Nasal Spray Wash
Calcium Glycerophosphate Nasal Spray Wash - Allergic Rhinitis
Phase 1 / Phase 2CompletedDrexel University172012-05-012015-05-25
Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)
Phenylephrine HCl Extended Release, Phenylephrine HCl Immediate Release - Nasal Congestion
Phase 1CompletedBayer242011-05-012015-02-23
To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine
Paracetamol 500 mg/Phenylephrine 5 mg tablets, Paracetamol 1000 mg/Phenylephrine 10 mg sachet - Respiratory Tract Infections
Phase 1CompletedMcNeil AB402010-03-012012-07-10
Pharmacokinetic Study of Bilastine in Children From 2 to < 12 Years of Age With Either Allergic Rhinoconjunctivitis (AR) or Chronic Urticaria (CU)
Bilastine - Allergic Rhinoconjunctivitis, Chronic Urticaria
Phase 1 / Phase 2CompletedFaes Farma, S.A.362010-01-012012-09-26
Study of Polyester Implants for the Treatment of External Nasal Valve Collapse (NVC)
Polyester Implants - Nasal Alar Collapse, Bilateral
Phase 1 / Phase 2TerminatedMedtronic Xomed, Inc.452008-04-012012-01-06
Heliox in Experimental Upper Airway Obstruction
HELIOX - Airway Obstruction, Dyspnea
Phase 1 / Phase 2CompletedUniversity of Witten/Herdecke442007-11-012008-11-21
Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride
Diphenhydramine hydrochloride - Nasal Congestion
Phase 1CompletedJohnson & Johnson Consumer and Personal Products Worldwide362006-10-012011-09-08

Narrower conditions

Nasal Obstruction (7)  ·  Sneezing (3)  ·  Rhinitis, Allergic (2)  ·  Rhinitis, Allergic, Seasonal (2)  ·  Apnea (1)  ·  Chronic Urticaria (1)  ·  Dyspnea (1)  ·  Erythema (1)  ·  Headache (1)  ·  Hypersensitivity (1)  ·  Nasal Alar Collapse, Bilateral (1)  ·  Pruritus (1)  ·  Respiratory Tract Infections (1)  ·  Rhinitis (1)

Broader conditions

Respiration Disorders (10)  ·  Respiratory Insufficiency (10)  ·  Respiratory Tract Diseases (10)  ·  Nose Diseases (7)  ·  Otorhinolaryngologic Diseases (7)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Signs and Symptoms (6)  ·  Signs and Symptoms, Respiratory (5)  ·  Hypersensitivity, Immediate (3)  ·  Immune System Diseases (3)  ·  Respiratory Hypersensitivity (3)  ·  Hypersensitivity (2)  ·  Infections (2)  ·  Rhinitis (2)

Interventions

Acetaminophen (1)  ·  Diphenhydramine (1)  ·  Influenza Vaccines (1)  ·  Oxymetazoline (1)  ·  Phenylephrine (1)  ·  alpha 1-Antichymotrypsin (1)  ·  bilastine (1)  ·  heliox (1)

Sponsors

5i Sciences, Inc. (1)  ·  Bayer (1)  ·  Drexel University (1)  ·  Faes Farma, S.A. (1)  ·  Johnson & Johnson Consumer and Personal Products Worldwide (1)  ·  McNeil AB (1)  ·  Medtronic Xomed, Inc. (1)  ·  Mylan Pharmaceuticals Inc (1)  ·  Shandong Cancer Hospital and Institute (1)  ·  University of Witten/Herdecke (1)

Countries

United States (3)  ·  Germany (2)  ·  Australia (1)  ·  China (1)  ·  Ireland (1)  ·  Sweden (1)

Top investigators

Edward S Schulman, MD (1)  ·  Elisabeth Kruse, PhD (1)  ·  Gunilla Hedlin, Prof. Dr. (1)  ·  Hubert Trubel, MD (1)  ·  Lennart Nordvall, Prof. Dr (1)  ·  Melissa Israel, BS (1)  ·  Noel E Cranswick, Prof. Dr. (1)  ·  Peter Le Souef, Prof. Dr. (1)  ·  Stefan Zielen, Prof. Dr. (1)  ·  Terry L Donat, MD (1)  ·  Ulrich Wahn, Prof. Dr. (1)  ·  Walter Coyle, M.D. (1)

Results publications

PMID 27110692, PMID 30850876

NIH funding

2009 (2)